Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. announced that at its AGM held on May 30, 2023, shareholders approved the election of Ms. Xue Yan as an executive Director. The company also approved the election of Mr. Wang Hong Guang, Mr. Lam Siu Wing and Mr. Xu Pei Long as an independent non-executive Directors. After AGM, Mr. Wang Hai Bo, Mr. Su Yong, Mr. Zhou Zhong Hui, Mr. Lam Yiu Kin, Mr. Xu Qing and Mr. Yang Chun Bao has retired upon expiry of their respective terms of office as Directors of the Company.

As disclosed in the announcement of the Company dated 27 March 2023, each of the abovementioned Directors has confirmed with the Company that they have no disagreement with the Company and there is no other matter in relation to their retirement that needs to be brought to the attention of the Shareholders and the Stock Exchange. Strategy Committee of the eighth session of the Board: Mr. Zhao Da Jun, Mr. Wang Hong Guang and Mr. Xu Pei Long. Mr. Zhao Da Jun was elected as the chairman of the committee; Audit Committee of the eighth session of the Board: Mr. Lam Siu Wing, Mr. Shen Bo and Mr. Wang Hong Guang.

Mr. Lam Siu Wing was elected as the chairman of the committee; Remuneration Committee of the eighth session of the Board: Wang Hong Guang, Mr. Lam Siu Wing and Mr. Xu Pei Long. Mr. Wang Hong Guang was elected as the chairman of the committee; Nomination Committee of the eighth session of the Board: Mr. Xu Pei Long, Mr. Zhao Da Jun and Mr. Lam Siu Wing. Mr. Xu Pei Long was elected as the chairman of the committee.